These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24475255)

  • 21. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
    Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
    Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
    Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
    World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma.
    Chen J; Xu X; Wu J; Ling Q; Wang K; Wang W; Zhang M; Shen Y; Zhou L; Xie H; Zheng S
    PLoS One; 2014; 9(3):e93128. PubMed ID: 24676010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences.
    Zheng SS; Xu X; Wu J; Chen J; Wang WL; Zhang M; Liang TB; Wu LM
    Transplantation; 2008 Jun; 85(12):1726-32. PubMed ID: 18580463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical resection versus liver transplantation for hepatocellular carcinoma within the Hangzhou criteria: a preoperative nomogram-guided treatment strategy.
    Li Y; Ruan DY; Jia CC; Zhao H; Wang GY; Yang Y; Jiang N
    Hepatobiliary Pancreat Dis Int; 2017 Oct; 16(5):480-486. PubMed ID: 28992879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hangzhou criteria for liver transplantation in hepatocellular carcinoma: a single-center experience.
    Lei JY; Wang WT; Yan LN
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):200-4. PubMed ID: 23995766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short- and long-term outcomes after salvage liver transplantation versus primary liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Zhu Y; Dong J; Wang WL; Li MX; Lu Y
    Transplant Proc; 2013 Nov; 45(9):3329-42. PubMed ID: 24182812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention-to-treat analysis.
    de Haas RJ; Lim C; Bhangui P; Salloum C; Compagnon P; Feray C; Calderaro J; Luciani A; Azoulay D
    Hepatology; 2018 Jan; 67(1):204-215. PubMed ID: 28806477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel nomogram for prognosis stratification in salvage liver transplantation: a national-wide study with propensity score matching analysis in China.
    Wang K; Gao F; Dong S; Ding J; Dong L; Shao C; Wang Z; Qiu X; Wei X; Wang Z; Yang J; Xia Q; Zheng S; Xu X
    Hepatobiliary Surg Nutr; 2023 Dec; 12(6):854-867. PubMed ID: 38115922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-Center Experience of Recurrence Patterns and Survival Analyses of Patients With Hepatocellular Carcinoma and Liver Transplant.
    Rahatli S; Ayvazoglu Soy EH; Oguz A; Altundag O; Moray G; Haberal M
    Exp Clin Transplant; 2020 Apr; 18(2):201-205. PubMed ID: 32279656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of multiple liver resections prior to salvage liver transplantation on survival in patients with recurrent HCC.
    Hu Z; Zhang Q; Zhou J; Li Z; Xiang J; Zhou L; Wu J; Zhang M; Zheng S
    BMJ Open; 2015 Sep; 5(9):e008429. PubMed ID: 26353871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of [
    Ye YF; Wang W; Wang T; Yu J; Geng L; Yu SF; Yan S; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):257-263. PubMed ID: 28603093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma.
    Yokoi H; Isaji S; Yamagiwa K; Tabata M; Nemoto A; Sakurai H; Usui M; Uemoto S
    J Hepatobiliary Pancreat Surg; 2006; 13(2):123-30. PubMed ID: 16547673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of salvage liver transplantation.
    Guerrini GP; Gerunda GE; Montalti R; Ballarin R; Cautero N; De Ruvo N; Spaggiari M; Di Benedetto F
    Liver Int; 2014 Jul; 34(6):e96-e104. PubMed ID: 24517642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria).
    Llovet JM; Pavel M; Rimola J; Diaz MA; Colmenero J; Saavedra-Perez D; Fondevila C; Ayuso C; Fuster J; Ginès P; Bruix J; Garcia-Valdecasas JC
    Liver Transpl; 2018 Mar; 24(3):369-379. PubMed ID: 29140601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Living donor liver transplantation for hepatocellular carcinoma.
    Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
    Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.